Adsorption and Infectivity of Human Immunodeficiency Virus Type 1 Are Modified the Fluidity of the Plasma Membrane for Multiple-Site Binding

Microbiology and Immunology

Volumn 48, Issue 4, 2004, Pages 347-355

  Harada, Shinji ^a   Akaike, Takaaki ^a   Yusa, Keisuke ^a   Maeda, Yosuke ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

HIV 1; Membrane fluidity; Multiple site binding

Indexed keywords

GLYCOPROTEIN GP 120; HLA ANTIBODY; T 140;

ARTICLE; BINDING SITE; CELL MEMBRANE; CELL MEMBRANE FLUIDITY; CONTROLLED STUDY; CORRELATION ANALYSIS; DATA ANALYSIS; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INHIBITION KINETICS; MEMBRANE BINDING; PROTEIN FUNCTION; REGULATORY MECHANISM; TEMPERATURE; TEMPERATURE DEPENDENCE; VIRUS ADSORPTION; VIRUS INFECTIVITY;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 1942421745     PISSN: 03855600     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2004.tb03516.x     Document Type: Article

References (32)

1. Berger, E.A. 1997. HIV entry and tropism: the chemokine receptor connection. AIDS 11 (suppl A): S3-S16.
2. Cecilia, D., KewalRamani, V.N., O'Leary, J., Volsky, B., Nyambi, P., Burda, S., Xu, S., Littman, D.R., and Zolla-Pazner, S. 1998. Neutralization profiles of primary human immunodeficiency virus type 1 isolates in the context of coreceptor usage. J. Virol. 72: 6988-6996.
3. Clapham, P.R., and McKnight, A. 2002. Cell surface receptors, virus entry and tropism of primate lentiviruses. J. Gen. Virol. 83: 1809-1829.
4. Dales, S. 1973. Early events in cell-animal virus interactions. Bacteriol. Rev. 37: 103-135.
5. Dragic, T. 2001. An overview of the determinants of CCR5 and CXCR4 coreceptor function. J. Gen. Virol. 82: 1807-1814.
6. Estes, J.D., Keele, B.F., Tenner-Racz, K., Racz, P., Redd, M.A., Thacker, T.C., Jiang, Y., Lloyd, M.J., Gartner, S., and Burton, G.F. 2002. Follicular dendritic cell-mediated up-regulation of CXCR4 expression on CD4 T cells and HIV pathogenesis. J. Immunol. 169: 2313-2322.
7. Fortin, J., Cantin, R., Lamontagne, G., and Tremblay, M. 1997. Host-derived ICAM-1 glycoproteins incorporated on human immunodeficiency virus type 1 are biologically active and enhance viral infectivity. J. Virol. 71: 3588-3596.
8. Frey, S., Marsh, M., Gunther, S., Pelchen-Matthews, A., Stephens, S., and Stegmann, T. 1995. Temperature dependence of cell-cell fusion induced by the envelope glycoprotein of human immunodeficiency virus type 1. J. Virol. 69: 1462-1472.
9. Golding, H., Zaitseva, M., Rosny, E., King, L.R., Manischewitz, J., Sidorov, I., Gorny, M.K., Zolla-Pazner, S., Dimitrov, D.S., and Weiss, C.D. 2002. Dissection of human immunodeficiency virus type 1 entry with neutralizing antibodies to gp41 fusion intermediates. J. Virol. 76: 6780-6790.
10. Harada, S., Koyanagi, Y., and Yamamoto, N. 1985. Infection of HTLV-III/LAV in HTLV-I-carrying cells MT-2 and MT-4 and application in a plaque assay. Science 229: 563-566.
11. Heerklotz, H. 2002. Triton promotes domain formation in lipid raft mixtures. Biophys. J. 83: 2693-2701.
12. Hoffman, T.L., and Doms, R.W. 1998. Chemokines and coreceptors in HIV/SIV-host interactions. AIDS 12 (suppl A): S17-S26.
13. Kimpton, J., and Emerman, M. 1992. Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated β-galactosidase gene. J. Virol. 66: 2232-2239.
14. Kuhmann, S.E., Platt, E.J., Kozak, S.L., and Kabat, D. 2000. Cooperation of multiple CCR5 coreceptors is required for infections by human immunodeficiency virus type 1. J. Virol. 74: 7005-7015.
15. Landau, N.R., Page, K.A., and Littman, D.R. 1991. Pseudotyping with human T-cell leukemia virus type I broadens the human immunodeficiency virus host range. J. Virol. 65: 162-169.
16. Layne, S.P., Merges, M.J., Dembo, M., Spouge, J.L., and Nara, P.L. 1990. HIV requires multiple gp120 molecules for CD4-mediated infection. Nature 346: 277-279.
17. Lonberg-Holm, K., and Philipson, L. 1969. Early events of virus-cell interaction in an adenovirus system. J. Virol. 4: 323-338.
18. Loura, L.M., Fedorov, A., and Prieto, M. 2001. Fluid-fluid membrane microheterogeneity: a fluorescence resonance energy transfer study. Biophys. J. 80: 776-788.
19. Maeda, Y., Foda, M., Matsushita, S., and Harada, S. 2000. Involvement of both the V2 and V3 regions of the CCR5-tropic human immunodeficiency virus type 1 envelope in reduced sensitivity to macrophage inflammatory protein 1α. J. Virol. 74: 1787-1793.
20. Masuda, T., Matsushita, S., Kuroda, M.J., Kannagi, M., Takatsuki, K., and Harada, S. 1990. Generation of neutralization-resistant HIV-1 in vitro due to amino acid interchanges of third hypervariable env region. J. Immunol. 145: 3240-3246.
21. Miller, E.D., Duus, K.M., Townsend, M., Yi, Y., Collman, R., Reitz, M., and Su, L. 2001. Human immunodeficiency virus type 1 IIIB selected for replication in vivo exhibits increased envelope glycoproteins in virions without alteration in coreceptor usage: separation on in vivo replication from macrophage tropism. J. Virol. 75: 8498-8506.
22. Morgan, J.R., LeDoux, J.M., Snow, R.G., Tompkins, R.G., and Yarmush, M.L. 1995. Retrovirus infection: effect of time and target cell number. J. Virol. 69: 6994-7000.
23. Muramatsu, K., Masumizu, T., Maitani, Y., Hwang, S.H., Kohno, M., Takayama, K., and Nagai, T. 2000. Electron spin resonance studies of dipalmitoylphosphatidylcholine liposomes containing soybean-derived sterylglucoside. Chem. Pharm. Bull. 48: 610-613.
24. Picard, L., Simmons, G., Power, C.A., Meyer, A., Weiss, R.A., and Clapham, P.R. 1997. Multiple extracellular domains of CCR-5 contribute to human immunodeficiency virus type 1 entry and fusion. J. Virol. 71: 5003-5011.
25. Platt, E.J., Wehrly, K., Kuhmann, S.E., Chesebro, B., and Kabat, D. 1998. Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1. J. Virol. 72: 2855-2864.
26. Platt, E.J., Kuhmann, S.E., Rose, P.P., and Kabat, D. 2001. Adaptive mutations in the V3 loop of gp120 enhance fusogenicity of human immunodeficiency virus type 1 and enable use of a CCR5 coreceptor that lacks the amino-terminal sulfate region. J. Virol. 75: 12266-12278.
27. Singer, S.J., and Nicolson, G.L. 1972. The fluid mosaic model of the structure of cell membrane. Science 175: 720-731.
28. Song, W., Yahara, S., Maeda, Y., Yusa, K., Tanaka, Y., and Harada, S. 2001. Enhanced infection of an X4 strain of HIV-1 due to capping and colocalization of CD4 and CXCR4 induced by capsianoside G, a diterpene glycoside. Biochem. Biophys. Res. Commun. 284: 423-429.
29. Tokunaga, K., Greenberg, M.L., Morse, M.A., Cumming, R.I., Lyerly, H.K., and Cullen, B.R. 2001. Molecular basis for cell tropism of CXCR4-dependent human immunodeficiency virus type 1 isolates. J. Virol. 75: 6776-6785.
30. Tamamura, T., Xu, Y., Hattori, T., Zhang, X., Arakaki, R., Kanbara, K., Omagari, A., Otaka, A., Ibuka, T., Yamamoto, N., Nakashima, H., and Fujii, N. 1998. A low-molecular-weight inhibitor against the chemokine receptor CXCR4: a strong anti-HIV peptide T140. Biochem. Biophys. Res. Commun. 253: 877-882.
31. Wu, L., Paxton, W.A., Kassam, N., Ruffing, N., Rottman, J.B., Sullivan, N., Choe, H., Sodroski, J., Newman, W., Koup, R.A., and Mackay, C.R. 1997. CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro. J. Exp. Med. 185: 1681-1691.
32. Yee, J., Miyanohara, A., LaPorte, P., Bouic, K., Burns, J.C., and Friedmann, T. 1994. A general method for the generation of high-titer, pantropic retroviral vector: highly efficient infection of primary hepatocytes. Proc. Natl. Acad. Sci. U.S.A. 91: 9564-9568.